Atlas Trials

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis

Clinical trial NCT04682639 · COMPLETED

Trial details

NCT number
NCT04682639
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Eosinophilic Esophagitis
Start date
2020-12-15
Primary completion
2022-09-30
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.